Vaxcyte, Inc.
(PCVX - NASDAQ)
59,62 USD
📋 Profilo Aziendale

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases.

|